• A
  • A
  • A
  • ABC
  • ABC
  • ABC
  • А
  • А
  • А
  • А
  • А
Regular version of the site
28Th29Fr30Sa
2020, January
1We2Th3Fr4Sa5Su6Mo7Tu8We9Th10Fr11Sa12Su13Mo14Tu15We16Th17Fr18Sa19Su20Mo21Tu22We23Th24Fr25Sa26Su27Mo28Tu29We30Th31Fr
2020, February
1Sa2Su3Mo4Tu5We6Th7Fr8Sa9Su10Mo11Tu12We13Th14Fr15Sa16Su17Mo18Tu19We20Th21Fr22Sa23Su24Mo25Tu26We27Th28Fr29Sa
2020, March
1Su2Mo3Tu4We5Th6Fr7Sa8Su9Mo10Tu11We12Th13Fr14Sa15Su16Mo17Tu18We19Th20Fr21Sa22Su23Mo24Tu25We26Th27Fr28Sa29Su30Mo31Tu
2020, May
1Fr2Sa3Su4Mo5Tu6We7Th8Fr9Sa10Su11Mo12Tu13We14Th15Fr16Sa17Su18Mo19Tu20We21Th22Fr23Sa24Su25Mo26Tu27We28Th29Fr30Sa31Su
2020, August
1Sa2Su3Mo4Tu5We6Th7Fr8Sa9Su10Mo11Tu12We13Th14Fr15Sa16Su17Mo18Tu19We20Th21Fr22Sa23Su24Mo25Tu26We27Th28Fr29Sa30Su31Mo
2020, November
1Su2Mo3Tu4We5Th6Fr7Sa8Su9Mo10Tu11We12Th13Fr14Sa15Su16Mo17Tu18We19Th20Fr21Sa22Su23Mo24Tu25We26Th
7
  • Today
  • Tomorrow

Thursday, November 26

11:00

Vladimir Apanovich to speak on 'The Role of Inter- and Intracultural Mental Variations'

online
13:00

Department of Applied Economics seminar on 'The Structure of Multinational Sales under Demand Risk'

online
16:20

ICEF and FES seminar on 'Behavioral Neural Networks'

online
18:10

CInSt Research Seminar 'Hunting for the Discouragement Effect in Contests'

online

Friday, November 27

Illustration for news: ‘A Completely New Platform, Never Studied or Used Before’: mRNA by Pfizer vs. Sputnik V Viral Vectors

‘A Completely New Platform, Never Studied or Used Before’: mRNA by Pfizer vs. Sputnik V Viral Vectors

One of the biggest headlines of recent days has been the announcement made by Pfizer, a U.S.-based company, and BioNTech, Germany, that BNT162b2, a COVID-19 vaccine they are developing, has proved to be 90% effective in its Phase 3 clinical trial. The news was met with big excitement all over the world. However, the Pfizer-BioNTech vaccine is based on a new platform, which is still understudied. According to protocol, its trial will be complete only in 2022. IQ talked to Larisa Popovich, Director of the HSE Institute for Health Economics, about the differences between the U.S.-German and the Russian Sputnik V vaccines, and about the chances of beating COVID-19 with massive immunization in the upcoming months.

Illustration for news: From Chains to Art Therapy: The Evolution of Mental Health Care

From Chains to Art Therapy: The Evolution of Mental Health Care

Mental health disorders are among the leading worldwide causes of disease and long-term disability. This issue has a long and painful history of gradual de-stigmatization of patients, coinciding with humanization of therapeutic approaches. What are the current trends in Russia regarding this issue and in what ways is it similar to and different from Western countries? IQ.HSE provides an overview of this problem based on research carried out by Svetlana Kolpakova.

Illustration for news: Motor Cortex Influences Word Comprehension

Motor Cortex Influences Word Comprehension

Researchers from HSE, Northumbria University, and Aarhus University have experimentally confirmed the hypothesis, whereby comprehension of a word’s meaning involves not only the ‘classic’ language brain centres but also the cortical regions responsible for the control of body muscles, such as hand movements. The resulting brain representations are, therefore, distributed across a network of locations involving both areas specialised for language processing and those responsible for the control of the associated action. The results have been published in the journal Neuropsychologia.

Fear and Uncertainty Lead to AIDS Denialism

December 1 marked World AIDS Day, the purpose of which is to increase global awareness of the disease. Researchers from HSE’s campus in St. Petersburg have spent the last two years studying a movement of individuals called ‘AIDS dissidents,’ or people who deny the existence of AIDS. Peter Meylakhs, Senior Research Fellow with the International Centre for Health Economics, Management, and Policy at HSE St. Petersburg, discusses some of his research results below.

Illustration for news: Performance Motivating Factors Reported by Russian Doctors

Performance Motivating Factors Reported by Russian Doctors

Interesting work, the desire to help patients, and money – these are the three key factors which motivate Russian doctors to perform, while career ambitions remain a secondary consideration, according to HSE research. Alexander Temnitsky, Leading Research Fellow of the HSE Centre for Health Policy, studied Russian doctors’ personal motives driving their performance between 2007 and 2014. 

HSE Researchers Help Treat Cancer in Children

HSE School of Data Analysis and Artificial Intelligence is conducting research for Federal Research Center of Pediatric Hematology, Oncology, and Immunology on how the treatment response might vary depending on the patient's physiology, such as the state of the internal organs and blood, and what the role of genetics is.

A Genuine Challenge for Humanity in the 21st Century

Professor Paul Kind, University of Leeds, led the International Centre for Health Economics, Management and Policy seminar at the HSE St Petersburg.

Russians Vulnerable to Ischemia and Stroke

Over the past two decades, the average life expectancy in Russia has increased by 2.3 years for women and 1.4 years for men, according to a recently published paper based on the WHO's Global Burden of Disease (GBD) assessment – a major epidemiological study by a group of international experts, including Vasily Vlassov, Professor of the HSE Department of Health Care Administration and Economy.

Healthy Russians Appreciate Doctors More

Overall, Russians tend to be satisfied with their country's health care system, particularly when they do not need to deal with it; however, those with recent first-hand experience of healthcare often complain about the lack of professionalism and the decline in free medical services, according to Sergey Shishkin, Head of HSE's Department of Health Care Administration and Economy, and Natalia Kochkinaand Marina Krasilnikova, sociologists with the Levada Centre, in their paper Health Care Service Availability and Quality as Assessed by the Russian Public.

15

U.S. dollars, or 11 euros, was the amount spent per person in Russia in 2014 on preventing cardiovascular disease.

12